<link rel="stylesheet" href="styles.f3b1fba60ec7970c.css">

Pharmacological modulation of voltage-gated ion channels by small molecules

dc.contributor.advisorVarga , Zoltán
dc.contributor.authorDomingos, Geraldo
dc.contributor.authorvariantDomingos, Geraldo
dc.contributor.departmentMolekuláris orvostudomány doktori iskolahu
dc.contributor.submitterdepÁltalános Orvostudományi Kar
dc.date.accessioned2026-10-19T08:15:30Z
dc.date.available2026-10-19T08:15:30Z
dc.date.defended2026-10-06
dc.date.issued2026
dc.description.abstractVoltage-Gated Ion Channels (VGIC) are transmembrane proteins that form pathways for ions to cross the plasma membrane controlled by the cellular membrane potential. They are at the core of many physiological, pathophysiological and pharmacological processes involved in electrical signaling such as neurotransmission, muscle contraction and hormone secretion. Malfunctioning or changes in the expression levels of these proteins results in a variety of disorders named channelopathies. Thus, VGICs serve as targets for a broad array of pharmacological interventions, including small molecules, gene therapies and antisense oligonucleotides. In my research, I worked with small molecules targeting voltage-gated ion channels, developed by our pharmaceutical chemist collaborators at the University of Ljubljana in Slovenia. We aimed for their in-depth biophysical characterization and to unveil their mechanisms of action for research applications and potentially for future therapeutic use. We first searched for a novel inhibitor targeting specifically the voltage-gated proton channel, HV1. By using the open structure of the channel, our collaborators performed virtual screening and identified hit molecules that we tested experimentally in our system. The most potent compound was fully characterized in detail to understand its biophysical parameters and mechanism of action by using standard patch clamp methods. We further found that the compound also inhibited other off-target channels at higher concentrations. However, when tested at lower concentrations, the compound unveiled an interesting mechanism of action that was further characterized on NaV1.5 KV1.3 channels, which have some similar but also some distinct gating properties. By using a variety of voltage protocols and patch clamping configurations, the molecule named NZ-58 was biophysically characterized and its interaction mechanism with the VSDs of the voltage gated ion channel was unveiled.
dc.format.extent93
dc.identifier.urihttps://hdl.handle.net/2437/415920
dc.language.isoen
dc.subjectVoltage-gated ion channels
dc.subjectSmall molecule inhibitor
dc.subjectVoltage sensor
dc.subjectPatch-clamp electrophysiology
dc.subjectVoltage-gated proton channel
dc.subjectmolecular mechanism
dc.subjectbinding site
dc.subjectActivation kinetics
dc.subjectGating modulator
dc.subjectNaV1.5 channel activation
dc.subjectBrugada mutation
dc.subjectEnhanced charge transfer
dc.subject.disciplineElméleti orvostudományokhu
dc.subject.sciencefieldOrvostudományokhu
dc.titlePharmacological modulation of voltage-gated ion channels by small molecules
dc.title.translatedA feszültségfüggő ioncsatornák kis molekulákkal történő farmakológiai modulációja
dc.typePhD, doktori értekezéshu

Fájlok

Eredeti köteg (ORIGINAL bundle)

Megjelenítve 1 - 3 (Összesen 3)
Betöltés ...
Bélyegkép
Név:
Invitation.pdf
Méret:
9,66 KB
Formátum:
Adobe Portable Document Format
Leírás:
Invitation
Betöltés ...
Bélyegkép
Név:
GeraldoDomingos_Dissertation.pdf
Méret:
3,54 MB
Formátum:
Adobe Portable Document Format
Betöltés ...
Bélyegkép
Név:
GeraldoDomingos_thesis.pdf
Méret:
1 MB
Formátum:
Adobe Portable Document Format

Engedélyek köteg

Megjelenítve 1 - 1 (Összesen 1)
Betöltés ...
Bélyegkép
Név:
license.txt
Méret:
1,93 KB
Formátum:
Item-specific license agreed upon to submission
Leírás: